Diclofenac sodium from the NSAID group, which is frequently preferred in both human and veterinary medicine, was used. Diclofenac sodium has been put on the market under different names by many companies in Türkiye. Dikloron (tablet, ampoule), Voltaren (ampoule, eye drop), Miyadren (ampoule, tablet), Diclomec (gel, ampoule) are some examples
12.
In studies using diclofenac sodium, it has been reported to increase oxidative stress and cause histopathological changes in kidney, liver13, heart14 and testis15 tissues. In addition, it has been reported to have teratogenic effects in the spinal cortex16, increase sperm DNA damage17, cause deterioration in hematological values18 and stomach ulcers 19.
In this study, SOD1, one of the oxidative stress factors, was found to be statistically higher in the uterine tissue at the 2nd hour and 48th hour following DS administration compared to the control group (P<0.001). SOD1 level in ovarian tissue was found to be statistically higher at the 2nd hour following DS administration compared to the other groups (P<0.001). The results obtained are consistent with the drug's package insert. DS reaches its peak in the blood within two hours and begins to lose its effect after 48 hours8.
CAT levels were statistically decreased in uterine tissue samples taken at the 2nd hour, 48th hour and 7th day after DS administration compared to the control group (P<0.001). In ovarian tissue, it was determined that CAT activity was present only in the control group and there was no activity in the other groups (P<0.001). The CAT enzyme protects against oxidative stress by converting 6 million H202 molecules into H20 and O2 per minute. DS use reduces CAT enzyme activity in the uterus and stops it in the ovary for seven days, causing an increase in oxidative stress in these tissues20.
Studies have reported that oxidative stress causes mitochondrial dysfunction, oocyte senescence, triggering apoptosis, degeneration of cumulus cells, poor embryo quality, anomalies, decreased fertilization rates, ovulation disorders, problems in meiosis, shortened telomere length and shortened embryo life span21,22.
It was found that mPGES levels decreased in serum samples at the 2nd hour and increased at the 48th hour and 7th day compared to the control group (P<0.001). As with all NSAIDs, DS exerts its effect by inhibiting PGE synthesis. As stated in the package insert of the drug, the drug reaches its maximum level in the blood in the 2nd hour after administration and loses its effect in the 48th hour. It was determined that the PGE results obtained as a result of the analysis were in parallel with the drug's package insert information. It is known that low PGE level causes relaxation of uterine smooth muscles, while high PGE level negatively affects ovulation, fertilization and embryonal development23. In addition, NSAIDs have the side effect of triggering premature birth 24. Since PGE levels are important during reproduction and pregnancy periods, NSAID use is dangerous.
ERα levels were found to be higher at the 2nd hour, 48th hour and 7th day compared to the control group. ERβ levels were found to be higher at the 2nd, 48th hour and 7th day compared to the control group (P<0.001). Mechanistically, at the molecular level, inhibition of PGE stimulates estrogen synthesis by stimulating the activity of aromatase, the enzyme that converts androgens to estrogens in 2nd hour25. The increase in estrogen levels may be explained by the inhibition of PGE synthesis due to DS use. The increase in ERα and ERβ levels at 48th and 7th day is not compatible with the PGE level at the same time. However, as shown in Table 5, ERα increases at 48th hour and ERβ increases at 2nd hour compared to the control group. This may be explained by the fact that ERα and ERβ are present at different levels in all cells and tissues and differ in their distribution and release mechanisms 26. Therefore, the increase in ERα and ERβ levels is parallel with the pharmacological properties of the drug and the PGE level is related. Estrogen levels are of high importance during reproductive periods. Estrogen levels may cause inhibition of implantation during the mating period. Since high estrogen levels during implantation periods will decrease the fertility rate, estrogen levels should be low during this period27-30.
In this study, it was found that progesterone levels increased in the 2nd hour and 7th day after DS administration compared to the control group (P<0.001). The increase in PR levels at the 2nd hour has similar results with the study conducted by Salim et al31. It is known that the relationship between PR and PGE is inversely proportional in hormonal mechanism32. It is expected that the pharmacological properties of the drug used are compatible with the PGE level and the PR level shows an inverse ratio compared to PGE in the 2nd hour and 48th hour. PR level is expected to be at basal level in the hormonal mechanism of estrous cycle during ovulation and mating period. In this period, high PR levels constitute an obstacle for ovulation and fertilization 33-35.
In conclusion, it is observed that DS use causes negative changes in mRNA expression of some antioxidant enzymes and hormones in the reproductive system of female rats. In light of the data obtained from this study, it is recommended that the mating of female rats be postponed for seven days following the administration of DS, a common practice in both human and animal health.